Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The tumour suppressor gene TP53 is mutated in more than 50 % of human tumours, making it one of the most important cancer genes. We have investigated the role of TP53 in cytochrome P450 (CYP)-mediated metabolic activation of three polycyclic aromatic hydrocarbons (PAHs) in a panel of isogenic colorectal HCT116 cells with differing TP53 status. Cells that were TP53(+/+), TP53(+/-), TP53(-/-), TP53(R248W/+) or TP53(R248W/-) were treated with benzo[a]pyrene (BaP), dibenz[a,h]anthracene and dibenzo[a,l]pyrene, and the formation of DNA adducts was measured by (32)P-postlabelling analysis. Each PAH formed significantly higher DNA adduct levels in TP53(+/+) cells than in the other cell lines. There were also significantly lower levels of PAH metabolites in the culture media of these other cell lines. Bypass of the need for metabolic activation by treating cells with the corresponding reactive PAH-diol-epoxide metabolites resulted in similar adduct levels in all cell lines, which confirms that the influence of p53 is on the metabolism of the parent PAHs. Western blotting showed that CYP1A1 protein expression was induced to much greater extent in TP53(+/+) cells than in the other cell lines. CYP1A1 is inducible via the aryl hydrocarbon receptor (AHR), but we did not find that expression of AHR was dependent on p53; rather, we found that BaP-induced CYP1A1 expression was regulated through p53 binding to a p53 response element in the CYP1A1 promoter region, thereby enhancing its transcription. This study demonstrates a new pathway for CYP1A1 induction by environmental PAHs and reveals an emerging role for p53 in xenobiotic metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199 · cited 8×
“…TP53 tumour suppressor gene, which encodes the protein p53, is mutated in over 50 % of human tumours and is one of the most important cancer genes (Olivier et al. 2010). p53, often described as the guardian of the genome, is involved in multiple cellular functions; amongst these is the response…”
BackgroundInfluentialPreferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · cited 1×
“It has been shown that reductions in p53 dosage and function can impact on a cell’s ability to respond to DNA damage (Berger et al. 2011; Bunz et al. 1999).”
BackgroundThe expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
p53: traffic cop at the crossroads of DNA repair and recombination
Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544 · cited 2×
“DNA repair capacity Nucleotide excision repair (NER) is the main DNA repair pathway for the studied PAHs, and p53-dependent pathways affecting global NER have been identified (Ford 2005; Sengupta and Harris 2005).”
BackgroundRegulation of DNA damage recognition and nucleotide excision repair: another role for p53
Ford, J. M. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.04.005 · Cited by 117 · cited 1×
“DNA repair capacity Nucleotide excision repair (NER) is the main DNA repair pathway for the studied PAHs, and p53-dependent pathways affecting global NER have been identified (Ford 2005; Sengupta and Harris 2005).”
Background
Cited by
A Compendium of Mutational Signatures of Environmental Agents
Kucab, J. E., Zou, X., Morganella, S., Joel, M., Nanda, A. S., Nagy, E., Gomez, C., Degasperi, A., Harris, R., Jackson, S. P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.001 · Cited by 660
Self-citationBarnes, J. L., Zubair, M., John, K., Poirier, M. C., & Martin, F. L. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180519 · Cited by 318
Stiborová, M., Dračínská, H., Bořek-Dohalská, L., Klusoňová, Z., Holecová, J., Martínková, M., Schmeiser, H. H., & Arlt, V. M. (2018) · Toxicology · doi:10.1016/j.tox.2018.04.001 · Cited by 19
“Because CYP1A1 and 1B1 enzymes activate BaP to metabolites capable of forming DNA adducts (Stiborová et al., 2014, 2016a; Wohak et al., 2016; Krais et al., 2016; Sulc et al., 2016), their expression might determine the levels of BaP-DNA adducts.”
BackgroundSelf-citationPark, S., Park, N.-Y., Lim, J.-E., Shin, M.-Y., Kim, S., Moon, H.-B., Park, J., Kho, Y., & Choi, K. (2025) · Environment International · doi:10.1016/j.envint.2025.109726 · Cited by 7
Metadata
- Authors
- Wohak, L. E., Krais, A. M., Kucab, J. E., Stertmann, J., Øvrebø, S., Seidel, A., Phillips, D. H., & Arlt, V. M.
- Venue
- Archives of Toxicology
- Published
- 2014-11-15
- Volume
- 90
- Issue
- 2
- Pages
- 291-304
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2070655139
- Cited by
- 104
- References
- 6
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism. https://app.cochat.ai/papers/10.1007/s00204-014-1409-1
- The paper
- Wohak, L. E., Krais, A. M., Kucab, J. E., Stertmann, J., Øvrebø, S., Seidel, A., Phillips, D. H., & Arlt, V. M. (2016). Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism. Archives of Toxicology. https://doi.org/10.1007/s00204-014-1409-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.